Exact Sciences Corporation (EXK F) stock market data APIs
€57.9539
0.38(0.7%)
as of November 7, 2025
Try our APIs with
free plan!
Exact Sciences Corporation Financial Data Overview
Price chart is built with
Anychart
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The company also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Riskguard Test, a hereditary cancer test to understand their inherited risk of cancer. Its pipeline focus on advancing screening and diagnostic products, including risk assessment, screening and prevention, early disease diagnosis, adjuvant and/or neoadjuvant disease treatment, metastatic disease treatment selection, and recurrence monitoring. The company has license agreements with MAYO Foundation for Medical Education and Research and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Prev. Close
57.9539
Open
58.3322
High
57.9539
Low
58.3322
52 wk Range
33.8-60.53
Market Cap
11 059 M
Shares Outstanding
189 M
Revenue
3 082 M
Beta
1.472
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Exact Sciences Corporation data using free add-ons & libraries
Get Exact Sciences Corporation Fundamental Data
Exact Sciences Corporation Fundamental data includes:
- Net Revenue: 3 082 M
- EBITDA: 108 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-03
- EPS/Forecast: 0.16
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Exact Sciences Corporation News
New
Exact Sciences (EXAS) Is Up 6.3% After Oncoguard Liver Test Outperforms Ultrasound in ALTUS Study
Exact Sciences Corp. announced pivotal results from the ALTUS study, showing its Oncoguard Liver blood test outperformed the standard ultrasound in early-stage liver cancer detection and overall sensi...
Exact Sciences Announces Breakthrough Results from Landmark Study Demonstrating Superior Early Detection of Liver Cancer with Blood-Based Surveillance Test
Oncoguard® Liver blood test delivers seven times greater sensitivity for very early-stage hepatocellular carcinoma (HCC) versus standard of care ALTUS study is the largest prospective trial of a blo...
3 Companies That May Be Priced Below Their Estimated Value
As the U.S. stock market rebounds from a recent tech sector downturn, major indices like the Nasdaq, Dow Jones Industrial Average, and S&P 500 have shown resilience despite ongoing economic uncertaint...
Earnings Estimates Rising for Exact Sciences (EXAS): Will It Gain?
Exact Sciences (EXAS) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue sin...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
